Arima Genomics Closes Series A Financing

Represented Arima Genomics, Inc. in its $3 million Series A venture capital financing in a deal led by investors Agilent Technologies, Inc., Co-win Healthcare Fund II, L.P. and Vectr Ventures Fund II, LP. 

Arima Genomics is a developer of a gene sequencing technology designed to accelerate the understanding of genome sequence and structure toward their role in human health and disease.